Literature DB >> 12589523

Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys.

Donna M Platt1, Joshua S Rodefer, James K Rowlett, Roger D Spealman.   

Abstract

RATIONALE: The D2-like receptor partial agonist terguride has a profile of behavioral effects in rats that suggests potential benefit as a pharmacotherapy for cocaine addiction.
OBJECTIVES: The present study investigated the effects of terguride on cocaine- and food-maintained behavior in squirrel monkeys.
METHODS: Squirrel monkeys were trained to respond on a second-order schedule (FI 10 min, FR 10 or 30:S) of either i.v. cocaine injection or food pellet delivery. Additional monkeys were studied using quantitative observational techniques to construct side effect profiles. Under each procedure, the effects of terguride were compared with those of the reference D2-like receptor antagonist nemonapride and the D2-like receptor full agonist quinpirole.
RESULTS: Terguride and nemonapride, but not quinpirole, dose-dependently reduced cocaine-maintained behavior. In animals self-administering food, terguride decreased response rates at doses lower than those required to suppress cocaine-maintained behavior. Effective doses of terguride had no systematic effect on motor activity or muscle rigidity, whereas effective doses of nemonapride virtually eliminated motor activity and induced severe catalepsy. The primary observable effects of terguride were a modest increase in self-directed behavior (a D2-receptor agonist-like effect) at intermediate doses and a small increase in static posture (a D2-receptor antagonist-like effect) at the highest dose tested.
CONCLUSIONS: The results suggest that terguride has advantages over conventional D2-like receptor antagonists and agonists as a candidate pharmacotherapy for cocaine abuse; however, terguride significantly reduces food-maintained behavior at lower doses than those needed to decrease cocaine-maintained behavior suggesting limitations on the utility of terguride as a medication for cocaine addiction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12589523     DOI: 10.1007/s00213-002-1347-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  45 in total

1.  Effects of dopamine D(1-like) and D(2-like) agonists on cocaine self-administration in rhesus monkeys: rapid assessment of cocaine dose-effect functions.

Authors:  S B Caine; S S Negus; N K Mello
Journal:  Psychopharmacology (Berl)       Date:  2000-01       Impact factor: 4.530

2.  Cocaine-antagonist effects of limited-efficacy D1 agonists.

Authors:  J Bergman; S Rosenzweig-Lipson
Journal:  NIDA Res Monogr       Date:  1992

Review 3.  Role of D1 and D2 dopamine receptors in the behavioral effects of cocaine.

Authors:  R D Spealman; J Bergman; B K Madras; J B Kamien; K F Melia
Journal:  Neurochem Int       Date:  1992-03       Impact factor: 3.921

4.  Discriminative stimulus effects of cocaine in squirrel monkeys: lack of antagonism by the dopamine D2 partial agonists terguride, SDZ 208-911, and SDZ 208-912.

Authors:  R D Spealman
Journal:  Pharmacol Biochem Behav       Date:  1995-08       Impact factor: 3.533

5.  Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study.

Authors:  K Svensson; A Ekman; M F Piercey; W E Hoffmann; J T Lum; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

6.  A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule.

Authors:  E Izzo; C Orsini; G F Koob; L Pulvirenti
Journal:  Pharmacol Biochem Behav       Date:  2001-04       Impact factor: 3.533

7.  Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat.

Authors:  L Pulvirenti; C Balducci; M Piercy; G F Koob
Journal:  J Pharmacol Exp Ther       Date:  1998-09       Impact factor: 4.030

8.  Unusual interactions between the neuroleptic haloperidol, and the dopamine D2 partial agonist, terguride.

Authors:  D.N. Stephens; P.A. Löschmann; C. Lanzinger; H. Wachtel; A.M.J. Montgomery; L.J. Herberg
Journal:  Behav Pharmacol       Date:  1990       Impact factor: 2.293

Review 9.  New drugs for the treatment of schizophrenia.

Authors:  H Y Meltzer
Journal:  Psychiatr Clin North Am       Date:  1993-06

10.  Acute versus chronic haloperidol: relationship between tolerance to catalepsy and striatal and accumbens dopamine, GABA and acetylcholine release.

Authors:  P G Osborne; W T O'Connor; O Beck; U Ungerstedt
Journal:  Brain Res       Date:  1994-01-14       Impact factor: 3.252

View more
  9 in total

Review 1.  Novel approaches to the treatment of cocaine addiction.

Authors:  Mehmet Sofuoglu; Thomas R Kosten
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

2.  Aripiprazole maintenance increases smoked cocaine self-administration in humans.

Authors:  Margaret Haney; Eric Rubin; Richard W Foltin
Journal:  Psychopharmacology (Berl)       Date:  2011-03-05       Impact factor: 4.530

3.  Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeys.

Authors:  Cindy Achat-Mendes; Peter Grundt; Jianjing Cao; Donna M Platt; Amy Hauck Newman; Roger D Spealman
Journal:  J Pharmacol Exp Ther       Date:  2010-05-21       Impact factor: 4.030

4.  Second-order stimuli do not always increase overall response rates in second-order schedules of reinforcement in the rat.

Authors:  David I G Wilson; E M Bowman
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

5.  Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapse.

Authors:  Matthew W Feltenstein; Phong H Do; Ronald E See
Journal:  Psychopharmacology (Berl)       Date:  2009-09-25       Impact factor: 4.530

6.  Phenylpiperazine derivatives with selectivity for dopamine D3 receptors modulate cocaine self-administration in rats.

Authors:  T H C Cheung; B C Nolan; L R Hammerslag; S M Weber; J P Durbin; N A Peartree; R H Mach; R R Luedtke; J L Neisewander
Journal:  Neuropharmacology       Date:  2012-08-31       Impact factor: 5.250

7.  Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice.

Authors:  Gunnar Sørensen; Thomas N Sager; Jørgen H Petersen; Lise T Brennum; Peter Thøgersen; Cecilie Hee Bengtsen; Morgane Thomsen; Gitta Wörtwein; Anders Fink-Jensen; David P D Woldbye
Journal:  Psychopharmacology (Berl)       Date:  2008-05-15       Impact factor: 4.530

Review 8.  Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development.

Authors:  Janet L Neisewander; Timothy H C Cheung; Nathan S Pentkowski
Journal:  Neuropharmacology       Date:  2013-08-23       Impact factor: 5.250

9.  Effects of aripiprazole and terguride on dopamine synthesis in the dorsal striatum and medial prefrontal cortex of preweanling rats.

Authors:  S D Iñiguez; A M Cortez; C A Crawford; S A McDougall
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.850

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.